U.S. stocks rallied sharply Monday, driven by renewed appetite for AI-related equities and growing confidence that the Federal Reserve could deliver a December interest rate cut. At the close, the Dow Jones Industrial Average jumped 1.5%, the S&P 500 rose 1.4%, and the tech-heavy NASDAQ surged 2.7%. Despite the strong session, major indexes remain on track for a weak November, with the S&P 500 down 3.5% month-to-date, the NASDAQ lower by 6.1%, and the Dow off 2.8%.
Tech stocks led the recovery as Alphabet shares soared more than 6%. Investor enthusiasm grew after the company’s Gemini AI model received a significant upgrade, intensifying competition with OpenAI. A leaked memo suggested OpenAI CEO Sam Altman acknowledged Google’s momentum could create “temporary economic headwinds.” Other AI leaders, including NVIDIA and Oracle, also posted solid gains, reinforcing optimism around the sector’s long-term growth.
Rate-cut expectations strengthened after recent comments from key Federal Reserve officials. New York Fed President John Williams signaled support for a December cut, a stance echoed by Fed Governor Christopher Waller, who noted that economic conditions have not shifted meaningfully since the last policy meeting. According to the CME FedWatch Tool, the probability of a 25-basis-point cut has climbed to nearly 69%, up from 44% just a week ago.
Investors now await a wave of delayed U.S. economic data, including producer inflation, retail sales, industrial production, and third-quarter GDP. Signs of slowing growth or a cooling labor market could bolster the case for more easing, though the Fed will meet in December without November’s full payroll data.
Geopolitical sentiment also improved after President Trump accepted an invitation to meet Chinese President Xi Jinping in April, raising hopes of progress in U.S.–China trade relations.
In corporate news, Agilent Technologies is set to report earnings after the close, while Novo Nordisk shares tumbled following weak Alzheimer’s trial results. Biogen stock climbed as analysts suggested Novo Nordisk’s setback could boost Biogen’s Alzheimer’s drug Leqembi.


Mexico Moves to Increase Tariffs on Asian Imports to Protect Domestic Industries
Russia Stocks End Flat as Energy and Retail Shares Show Mixed Performance
Fed Rate Cut Signals Balance Between Inflation and Jobs, Says Mary Daly
Japan Business Sentiment Hits Four-Year High, Boosting Expectations of BOJ Rate Hike
Modi and Trump Hold Phone Call as India Seeks Relief From U.S. Tariffs Over Russian Oil Trade
Wall Street Futures Dip as Broadcom Slides, Tech Weighed Down Despite Dovish Fed Signals
China’s Small Bank Consolidation Struggles as Profits Fall and Risks Persist
Australia’s Labour Market Weakens as November Employment Drops Sharply
Oil Prices Edge Higher as U.S. Seizes Sanctioned Venezuelan Tanker
Global Markets Slide as Tech Stocks Sink, Yields Rise, and AI Concerns Deepen
South Korea Extends Bond Market Stabilization Measures Amid Rising Financial Risks
Asian Currencies Steady as Fed Delivers Hawkish Rate Cut; Aussie and Rupee Under Pressure
Gold Prices Dip as Markets Absorb Dovish Fed Outlook; Silver Eases After Record High
ASX Shares Slide After ASIC Imposes A$150 Million Capital Requirement
Asian Stocks Rally as Tech Rebounds, China Lags on Nvidia Competition Concerns
Hong Kong Cuts Base Rate as HKMA Follows U.S. Federal Reserve Move
S&P 500 Slides as AI Chip Stocks Tumble, Cooling Tech Rally 



